Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-20 6:05 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 58,651,170 15.3% | 29,544,805 (+101.51%) | View |
| 2024-03-20 5:25 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 74,535,666 19.25% | 9,238,070 (+14.15%) | View |
| 2024-02-26 4:15 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | MILLENNIUM MANAGEMENT LLC | 15,037,065 5.2% | 15,037,065 (New Position) | View |
| 2024-02-14 3:32 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 7,975,374 9.9% | 80,623 (+1.02%) | View |
| 2024-02-13 5:14 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 4,133,939 5.21% | 177,971 (+4.50%) | View |
| 2024-01-12 2:04 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Neuberger Berman Group LLC | 4,382,584 11% | 46,481 (+1.07%) | View |
| 2024-01-09 5:13 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 65,297,596 19.71% | 27,715,250 (+73.75%) | View |
| 2024-01-09 4:46 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 29,106,365 9.5% | 20,817,249 (+251.14%) | View |
| 2024-01-08 5:00 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 7,042,413 2.4% | -755,041 (-9.68%) | View |
| 2023-11-22 4:15 pm Unchanged | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.5% | 0 (Unchanged) | View |
| 2023-10-16 4:30 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.5% | -34,705 (-0.42%) | View |
| 2023-07-07 1:27 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | PRIMECAP MANAGEMENT CO | 3,220,917 4.11% | -1,395,756 (-30.23%) | View |
| 2023-07-03 5:17 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 7,797,454 9.9% | -779,345 (-9.09%) | View |
| 2023-02-14 4:33 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | North Sound Trading LP | 2,396,400 3% | -1,978,600 (-45.23%) | View |
| 2023-02-14 1:18 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,323,821 9.5% | 220,294 (+2.72%) | View |
| 2023-02-14 10:26 am Purchase | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 7,894,751 9.9% | 308,846 (+4.07%) | View |
| 2023-02-09 4:02 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | PRIMECAP MANAGEMENT CO | 4,616,673 5.82% | -476,730 (-9.36%) | View |
| 2023-02-09 11:32 am Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 3,955,968 4.99% | 88,297 (+2.28%) | View |
| 2022-12-30 5:10 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 8,576,799 10.8% | -2,868,037 (-25.06%) | View |
| 2022-11-14 4:43 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | RA CAPITAL MANAGEMENT L.P. | 0 0% | -4,651,177 (Position Closed) | View |